Monoclonal antibody against muramyl peptides
View Patent ↗Disclosed is an isolated antibody or an antigen-binding fragment thereof The antibody is capable of binding to a muramyl peptide, or a derivative or an analog or a salt thereof. The muramyl peptide comprises muramic acid and an amino acid selected from the group consisting of alanine, isoglutamine, glutamic acid, and a salt thereof. Also disclosed are methods of producing the antibody, compositions comprising the antibody, methods of treating using the antibody, uses of the antibody, methods of detecting muramyl peptide, an assay for detecting muramyl peptide, an antibacterial agent, hybridomas and kits.
1. A method of prophylactically or therapeutically treating rheumatoid arthritis, comprising administering to a subject an isolated antibody or an antigen-binding fragment thereof, capable of binding to a muramyl peptide selected from the group consisting of N-acetylmuramyl-L-alanyl-D-isoglutamine, muramyl-L-alanyl-D-isoglutamine, N-acetylmuramyl-L-alanyl-D-glutamate, and muramyl-L-alanyl-D-glutamate; wherein the isolated antibody or an antigen-binding fragment thereof comprises a heavy chain variable domain comprising the amino acid sequence as set forth in SEQ ID NO: 3 and a light chain variable domain comprising the amino acid sequence as set forth in SEQ ID NO: 4.